Search Results

Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce that the Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter (VISABL-AFL) IDE clinical trial, commenced with two procedures performed at the Cardiovascular Institute of South Paris (ICPS) (https://icps.fr).

Imricor Medical Systems, Inc. (ASX:IMR) Imricor, the global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation products, is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with GE HealthCare.

Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR), the global leader in MRI-guided cardiac ablation products, is pleased to announce a sales collaboration with Optoacoustics Ltd, the world leader in innovative, high performance optical communication solutions for magnetic resonance (MR) applications.

Imricor Medical Systems, Inc. the worldwide leader in MRI-guided cardiac ablation products, is pleased to announce the first sales collaboration with Philips, a global leader in healthcare technology.

Feb. 5, 2020 17:40 UTC MINNEAPOLIS & DRESDEN, Germany--( BUSINESS WIRE )-- Imricor Medical Systems, Inc. ( Company or Imricor ) ( ASX:IMR ) is pleased to announce the first procedures using the Company’s products following CE mark of the Vision-MR Ablation Catheter have been performed at the Heart Center Dresden.

Imricor achieves commercial milestone with first customer contract

Imricor and MiRTLE Medical announce a joint development agreement to fully integrate MiRTLE’s MR compatible 12-lead ECG system with Imricor’s Advantage-MR™ EP Recorder/Stimulator System.

Imricor Medical Systems, Inc. the global leader in MRI-guided cardiac ablation products, is pleased to announce the Maastricht University Medical Centre+ in the Netherlands has commenced procedures since the extended lockdowns across Europe precluded elective surgeries.

Imricor Medical Systems, Inc. (ASX:IMR) today announces that it has received CE mark approval for its Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode. This follows earlier CE mark approval for Imricor to place its Advantage-MR EP Recorder/Stimulator System on the market in Europe

Philipp Sommer MD FHRS, Deputy Director of Dept. of Electrophysiology at the Helios Leipzig Heart Center, will present the results on Saturday, May 12 at 9:00 am ET